individually , an effective regimen ( greater than 83 % reduction in ventricular premature complexes and abolition of nonsustained ventricular tachycardia ) was found in 5 ( 24 % ) of 21 patients during therapy with disopyramide alone , in 3 ( 14 % ) receiving mexiletine alone and in 13 ( 62 % ) receiving combination therapy ( p less than 0.05 for combination therapy versus disopyramide or mexiletine ; p = ns for disopyramide versus mexiletine ) .
C0151636
ventricular premature complexes
C0025887
mexiletine